Reference health
Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives
00086-6/badge.svg){kind=icon}
40/40 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
6 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 40 checked references that resolve
resolves10.1093/eurheartj/ehz962
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
resolves10.1016/j.jacc.2015.02.020
Effect of Naturally Random Allocation to Lower Low-Density Lipoprotein Cholesterol on the Risk of Coronary Heart Disease Mediated by Polymorphisms in NPC1L1, HMGCR, or Both
resolves10.1001/jama.2016.13985
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
resolves10.1161/CIRCOUTCOMES.110.959247
A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
resolves10.1097/MOL.0000000000000330
The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity
resolves10.1001/jama.2017.11467
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
resolves10.1001/jama.2018.20045
Association of Triglyceride-Lowering <i>LPL</i> Variants and LDL-C–Lowering <i>LDLR</i> Variants With Risk of Coronary Heart Disease
resolves10.1371/journal.pmed.1003062
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
resolves10.1093/ije/dyy262
An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings
resolves10.1093/ije/dym276
The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine
resolves10.1371/journal.pmed.1001779
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
resolves10.1038/s41467-019-11558-2
A meta-analysis of genome-wide association studies identifies multiple longevity genes
resolves10.1038/s41588-018-0241-6
Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps
resolves10.1038/ng.3190
Efficient Bayesian mixed-model analysis increases association power in large cohorts
resolves10.1002/gepi.21965
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
resolves10.1093/ije/dyx102
Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption
resolves10.1093/ije/dyv080
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
resolves10.1002/sim.7492
Extending the MR‐Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy
resolves10.1038/s41588-018-0255-0
Distinguishing genetic correlation from causation across 52 diseases and complex traits
resolves10.7554/eLife.34408
The MR-Base platform supports systematic causal inference across the human phenome
resolves10.1042/bst0110639
Quantitative importance of different organs for cholesterol synthesis and low-density-lipoprotein degradation
resolves10.1194/jlr.M800238-JLR200
Cholesterol accumulation and diabetes in pancreatic β-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity
resolves10.1210/en.2002-220273
Low Density Lipoprotein Can Cause Death of Islet β-Cells by Its Cellular Uptake and Oxidative Modification
resolves10.1093/eurheartj/ehy357
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor
resolves10.1007/s00125-010-1691-2
Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice
resolves10.1194/jlr.R082271
Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding
resolves10.1001/jama.2015.1206
Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
resolves10.1016/S2213-8587(16)30396-5
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
resolves10.1056/NEJMoa1604304
Variation in<i>PCSK9</i>and<i>HMGCR</i>and Risk of Cardiovascular Disease and Diabetes
resolves10.7555/JBR.34.20190124
LDL, LDL receptors, and PCSK9 as modulators of the risk for type 2 diabetes: a focus on white adipose tissue
resolves10.1161/CIRCULATIONAHA.116.026560
Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus
resolves10.1093/ije/dyg070
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
The 6 references without a DOI — listed, not checked
no DOI — not checkedHigh-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease
no DOI — not checked10.1016/S2666-7568(21)00086-6_bib22
no DOI — not checkedAssessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic
no DOI — not checkedTesting and correcting for weak and pleiotropic instruments in two-sample multivariable mendelian randomisation
no DOI — not checked10.1016/S2666-7568(21)00086-6_bib31
no DOI — not checkedFamilial combined hyperlipidemia: current knowledge, perspectives, and controversies
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/s2666-7568(21)00086-6"><img src="https://citestamp.com/citestamped/10.1016/s2666-7568(21)00086-6/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[00086-6/badge.svg)](https://citestamp.com/citestamped/10.1016/s2666-7568(21)00086-6)